RAPT Therapeutics, Inc.: Nasdaq/NYSE listing notice — RAPT Therapeutics receives Nasdaq bid price deficiency notice; plans reverse stock split

RAPT Therapeutics, Inc.

Received Nasdaq notice on May 21, 2025: average closing bid price below $1.00 for 30 consecutive days.
Has 180 days (until November 17, 2025) to cure by closing at $1.00 for 10 consecutive business days.
Board approved 1-for-8 reverse stock split; stockholders vote on May 29, 2025 annual meeting.
If not cured, may transfer to Nasdaq Capital Market or face delisting; appeal to Panel possible.

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.95

RAPT Therapeutics, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5450(a)(1), 5810(c)(3)(A)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: minimum bid price
Rules: 5450(a)(1), 5810(c)(3)(A)

Exact text from the filing

May 21, 2025, RAPT Therapeutics, Inc. (the “Company”) received a notification letter from the Nasdaq Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that the average closing bid price of the Company’s shares of common stock was below the minimum closing bid price of $1.00 per share during the last 30 consecutive trading days (the “Notice”), as required for continued listing on the Nasdaq under Rule 5450(a)(1) of the Nasdaq’s Listing Rules (the “Rules”). The Notice has no immediate impact on the listing of the Company’s common stock, which will

View on SEC.gov

3 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

Source: SEC EDGAR

accession 0000950170-25-078341

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.